Prostate Specific Antigen (PSA) Testing Market
Prostate Specific Antigen (PSA) Testing Market - Global Industry Assessment & Forecast
Segments Covered
- By Test Type Preliminary Tests, Confirmatory Tests
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2022 |
Forecast Years: | 2023 - 2030 |
Historical Years: | 2017 - 2021 |
Revenue 2022: | USD 3.33 Billion |
Revenue 2030: | USD 7.74 Billion |
Revenue CAGR (2023 - 2030): | 11.10% |
Fastest Growing Region (2023 - 2030) | Asia Pacific |
Largest Region (2022): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
Prostate Specific Antigen (PSA) Testing Market Segment Analysis
- Prostate Specific Antigen (PSA) Testing Test Type Outlook (Revenue, USD Million, 2018 - 2030)
- Preliminary Tests
- Confirmatory Tests
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- U.S.
- U.S. Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- U.S. Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Canada
- Canada Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Canada Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Mexico
- Mexico Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Mexico Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
North America Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Europe
-
Europe Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- U. K.
- U.K. Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- U.K. Prostate Specific Antigen (PSA) Testing Market, by Test Type
- France
- France Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- France Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Germany
- Germany Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Germany Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Italy
- Italy Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Italy Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Spain
- Spain Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Spain Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Rest of Europe
- Rest of Europe Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Rest of Europe Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Europe Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Asia Pacific
-
Asia Pacific Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- China
- China Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- China Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Japan
- Japan Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Japan Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Germany
- Germany Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Germany Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
India
- India Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- India Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
South Korea
- South Korea Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- South Korea Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
South East Asia
- South East Asia Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- South East Asia Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Rest of Asia Pacific Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Asia Pacific Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Latin America
-
Latin America Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Brazil
- Brazil Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Brazil Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Argentina
- Argentina Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Argentina Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Rest of Latin America
- Rest of Latin America Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Rest of Latin America Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Latin America Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Middle East & Africa
-
Middle East & Africa Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- GCC Countries
- GCC Countries Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- GCC Countries Prostate Specific Antigen (PSA) Testing Market, by Test Type
- South Africa
- South Africa Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- South Africa Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Prostate Specific Antigen (PSA) Testing Market, by Test Type
- Preliminary Tests
- Confirmatory Tests
- Rest of Middle East & Africa Prostate Specific Antigen (PSA) Testing Market, by Test Type
-
Middle East & Africa Prostate Specific Antigen (PSA) Testing Market, by Test Type
- North America
FAQ
Frequently Asked Question
What is the global demand for Prostate Specific Antigen (PSA) Testing in terms of revenue?
-
The global Prostate Specific Antigen (PSA) Testing valued at USD 3.33 Billion in 2022 and is expected to reach USD 7.74 Billion in 2030 growing at a CAGR of 11.10%.
Which are the prominent players in the market?
-
The prominent players in the market are MDx Health (US), Myriad Genetics Inc (US)., Abbott Laboratories (US), F. Hoffman-La Roche AG (Switzerland), Siemens Healthineers AG (Germany), OPKO Health Inc. (US), and Genomic Health (US)..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 11.10% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Prostate Specific Antigen (PSA) Testing include
- Increased Level of Awareness
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Prostate Specific Antigen (PSA) Testing in 2022.